CCEL CRYO CELL INTERNATIONAL INC
Data as of close
Healthcare · Services-Misc Health & Allied Services, Nec
CRYO CELL INTERNATIONAL INC (CCEL) is a healthcare company in the Services-Misc Health & Allied Services, Nec industry, with a market capitalization of $43 million. Shares last traded at $5.35, near their 52-week high. Over the past year the stock is up 5.9%. Net profit margin is -6.2%, below the peer median of 5.4%. Revenue declined 1.3% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-08-31. Source: SEC EDGAR/XBRL.
CCEL Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-11-30 | $3M | $0.00 | — |
| 2024-11-30 | $2M | $0.00 | 503% |
| 2022-11-30 | $8M | $0.00 | 277% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q3 2026 | $0.16 | 2026-10-09 |
| Q2 2026 | $0.07 | 2026-07-15 |
| Q1 2026 | $0.01 | 2026-04-14 |
| Q4 2025 (derived) | -$0.46 | 2026-02-27 |
| FY 2025 | -$0.30 | 2026-02-27 |
| Q3 2025 | $0.09 | 2025-10-15 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Services-Misc Health & Allied Services, Nec peers
CCEL vs 11 industry peers (Services-Misc Health & Allied Services, Nec), by market cap. Data as of close
| DVA | DaVita | $11.7B | 12.70 | 0.82 | 6.5% | -1.02% |
| SHC | Sotera Health Co | $5.1B | 30.93 | 4.16 | 13.4% | -2.26% |
| PGNY | Progyny, Inc. | $2.3B | 28.71 | 1.72 | 6.0% | +0.72% |
| AGL | Agilon Health, Inc. | $1.5B | — | 0.25 | -3.9% | +2.46% |
| VMD | VIEMED HEALTHCARE, INC. | $360M | 24.80 | 1.19 | 4.8% | -2.48% |
| PARK | Park Dental Partners, Inc. | $100M | — | — | — | -0.54% |
| CCEL | CRYO CELL INTERNATIONAL INC | $43M | — | 1.39 | -6.2% | +3.38% |
| MGRX | MANGOCEUTICALS, INC. | $5M | — | 15.66 | — | -2.51% |
| BRTX | BioRestorative Therapies, Inc. | $2M | — | 5.34 | — | +6.38% |
| NIVF | NewGenIvf Group Ltd | — | — | — | — | -7.75% |
| FMS | Fresenius Medical Care Ag | — | — | — | — | +0.67% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.